SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-040382
Filing Date
2017-08-03
Accepted
2017-08-03 17:21:06
Documents
3
Period of Report
2017-07-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v472305_8k.htm 8-K 29260
2 EXHIBIT 10.1 v472305_ex10-1.htm EX-10.1 188901
3 EXHIBIT 99.1 v472305_ex99-1.htm EX-99.1 14112
  Complete submission text file 0001144204-17-040382.txt   233735
Mailing Address 10210 CAMPUS POINT DRIVE, SUITE 150 SAN DIEGO CA 92121
Business Address 10210 CAMPUS POINT DRIVE, SUITE 150 SAN DIEGO CA 92121 (858) 909-0749
Sevion Therapeutics, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-31326 | Film No.: 171006104
SIC: 8731 Services-Commercial Physical & Biological Research